Literature DB >> 19732829

Surface energy changes and their relationship with the dispersibility of salmeterol xinafoate powders for inhalation after storage at high RH.

Shyamal Das1, Ian Larson, Paul Young, Peter Stewart.   

Abstract

This study investigated the relationship between surface energy of micronized lactose, coarse lactose and salmeterol xinafoate and dispersibility from a mixture after storage at 75% RH. Surface energies, dispersibility, morphology, and the presence of amorphous domains were determined by inverse gas chromatography, twin stage impinger, scanning electron microscope and dynamic vapour sorption, respectively. The fine particle fraction of mixture decreased significantly in 4 weeks (P<0.05), reaching a static level in 3 months. Amorphous content was not detected in the micronized lactose, coarse lactose and salmeterol xinafoate. After conditioning stored samples at 75% RH for 2h, dispersive surface energy of both micronized and coarse lactose significantly decreased (P<0.05), while the polar surface energy of all significantly increased (P<0.05) resulting in significant increase in total surface energy after storage. After conditioning stored samples at 0% RH for 2h, no significant difference was observed in any surface energy parameter. This study concluded that the total surface energy increased during storage at high RH due to the adhered surface moisture. The mechanism of decreased dispersibility was related to increased capillary/solid bridging interactions and to possible increased interaction of contiguous particles due to increased polar surface energy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732829     DOI: 10.1016/j.ejps.2009.08.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

Review 1.  Multifunctional Role of Silica in Pharmaceutical Formulations.

Authors:  Yating Gao; Yue Zhang; Yanlong Hong; Fei Wu; Lan Shen; Youjie Wang; Xiao Lin
Journal:  AAPS PharmSciTech       Date:  2022-03-16       Impact factor: 3.246

2.  Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.

Authors:  Vaibhav Pathak; Heejun Park; Dmitry Zemlyanov; Sonal V Bhujbal; Maizbha Uddin Ahmed; Mohammad A K Azad; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2022-08-02       Impact factor: 4.580

Review 3.  Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices.

Authors:  Tushar Saha; Miguel E Quiñones-Mateu; Shyamal C Das
Journal:  Int J Pharm       Date:  2022-07-20       Impact factor: 6.510

4.  Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.

Authors:  Waseem Kaialy; Tariq Hussain; Amjad Alhalaweh; Ali Nokhodchi
Journal:  Pharm Res       Date:  2013-08-06       Impact factor: 4.200

5.  Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; David J Barlow; Gary P Martin; Darragh Murnane
Journal:  Int J Pharm       Date:  2013-02-19       Impact factor: 5.875

6.  Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.

Authors:  Christer Janson; Thomas Lööf; Gunilla Telg; Georgios Stratelis; Folke Nilsson
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-17       Impact factor: 2.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.